Trophos Overview

  • Founded
  • 1999
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 17
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $394M
Latest Deal Amount

Trophos General Information

Description

Operator of a clinical stage pharmaceutical company engaged in development of drugs for the treatment of neurological and cardiac diseases. The company involves screening chemical collections of small molecules on models of sick neurons, using the class of neurons affected in each type of disease.

Contact Information

Website
www.trophos.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Acquirer
Primary Office
  • Parc scientifique de Luminy
  • Case 931
  • 13288 Marseille
  • France
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Trophos Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Merger/Acquisition 03-Mar-2015 $394M 000.00 00000 Completed Generating Revenue
7. Grant 11-Oct-2012 00.00 000.00 Completed Generating Revenue
6. Grant 26-Mar-2009 00.00 000.00 Completed Generating Revenue
5. Grant 23-Dec-2008 00.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series C) 04-Sep-2007 000.00 000.00 Completed Generating Revenue
3. Grant 04-Sep-2007 000.00 000.00 Completed Generating Revenue
2. Early Stage VC 01-Apr-2003 $6.91M $22.6M Completed Startup
1. Early Stage VC $15.7M $15.7M Completed Startup
To view Trophos’s complete valuation and funding history, request access »

Trophos Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a clinical stage pharmaceutical company engaged in development of drugs for the treatment of neurological an
Biotechnology
Marseille, France
17 As of 2015
000.00
0000 0000-00-00
000000&0 000.00

00000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000000000000
South San Francisco, CA
00000 As of 0000
000.00
0000 0000-00-00
00000000000

00000000

cididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamc
0000000000000
Tübingen, Germany
000 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Trophos Competitors (77)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genentech Formerly VC-backed South San Francisco, CA 00000 000.00 00000000000
00000000 Formerly VC-backed Tübingen, Germany 000 00000 000000000 00000
00000000 Formerly VC-backed Needham, MA 00 00000 000000 - 000 00000
000000000 Corporation Illkirch-Graffenstaden, France 000 00000 000000000 00000
0000000 0000000000 Formerly VC-backed Newark, CA 00 00000 00000000 00000
You’re viewing 5 of 77 competitors. Get the full list »

Trophos Patents

Trophos Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20150056269-A1 Liposome comprising at least one cholesterol derivative Abandoned 25-Aug-2011 0000000000
FR-2979239-A1 Liposome comprising at least one cholesterol derivative Pending 25-Aug-2011 0000000000
US-20160339041-A1 Liposome comprising at least one cholesterol derivative Abandoned 25-Aug-2011 0000000000
JP-6162699-B2 Liposomes containing at least one cholesterol derivative Expired - Fee Related 25-Aug-2011 0000000000
JP-2014524460-A Liposomes containing at least one cholesterol derivative Granted 25-Aug-2011 A61K31/575

Trophos Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Trophos Former Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Amundi Private Equity Funds PE/Buyout Minority 000 0000 000000 0
Apicap Venture Capital Majority 000 0000 000000 0
Arch Capital Group Corporation Minority 000 0000 000000 0
Association Française contre les Myopathies Venture Capital Minority 000 0000 000000 0
CM-CIC Capital Privé Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 11 investors. Get the full list »